Effects of H-type Hypertension on Bone Metabolism Markers and Inflammatory Factors in Postmenopausal Women with Osteoporosis

doi:10.12114/j.issn.1007-9572.2018.32.008

Abstract

Abstract: Objective　To investigate the changes in bone metabolic markers and inflammatory factors in postmenopausal women with H-type hypertension complicated with osteoporosis.Methods　A total of 164 postmenopausal women diagnosed with osteoporosis and admitted to the Department of Geriatrics of the Third Affiliated Hospital of Soochow University between January 2015 and June 2016 were selected for this study.The patients were divided into three groups：the A group included 57 patients with only osteoporosis；the B group included 54 patients with osteoporosis complicated with ordinary hypertension；and the C group included 53 patients with osteoporosis complicated with H-type hypertension.The bone densities of the lumbar vertebrae （L1-4），left femoral neck，and femoral trochanter in the two groups were measured.The biomarkers N-terminal propeptide of type Ⅰ collagen （PINP），carboxy-terminal cross-linking telopeptide of type Ⅰ collagen （CTX），and inflammatory cytokine interleukin 6 （IL-6） were tested.Results　The bone densities of L1-4，neck，and femoral trochanter in the B and C groups were lower than those in the A group，and the levels of CTX and IL-6 were higher than those in the A group （P<0.05）.The bone densities of L1，L2，L4，neck，and femoral trochanter in the C group were lower，and the levels of CTX and IL-6 were higher，than those in the B group （P<0.05）.Conclusion　Hypertension increases the activity of osteoclasts and the expression of the inflammatory cytokine IL-6 in postmenopausal women.It also moderately increases the activity of osteoblasts；however，the bone resorption effect is significantly greater than the bone formation effect，thus increasing osteoporosis.H-type hypertension further increases the above effect in postmenopausal women，which in turn aggravates osteoporosis.Therefore，strengthening the control of blood pressure is particularly important in patients with H-type hypertension.

Key words: Hypertension, Osteoporosis, Postmenopause, Interleukin-6, Bone metabolism markers, Inflammatory factors

摘要： 目的　探讨绝经后女性H型高血压合并骨质疏松症患者骨代谢标志物及炎性因子的变化。方法　选取2015年1月—2016年6月苏州大学附属第三医院老年科收治的绝经后女性且既往明确诊断为骨质疏松症的患者164例为研究对象。根据患病情况将患者分为3组，单纯骨质疏松症患者为A组57例、普通高血压合并骨质疏松症患者为B组54例、H型高血压合并骨质疏松症患者为C组53例。测量各组患者腰椎（L1~4）、左侧股骨颈、股骨大粗隆骨密度，检测患者Ⅰ型原胶原N端前肽（PINP）、Ⅰ型胶原C端交联肽（CTX）及炎性因子白介素6（IL-6）水平。结果　B组和C组患者L1~4、股骨颈、股骨大粗隆骨密度较A组降低，CTX、IL-6水平较A组升高（P<0.05）；C组患者L1、L2、L4、股骨颈、股骨大粗隆骨密度较B组降低，CTX、IL-6水平较B组升高（P<0.05）。结论　高血压可以增强绝经后女性破骨细胞的活性及炎性因子IL-6的表达，亦可部分增强成骨细胞的活性，但骨吸收显著大于骨形成，从而引起骨质疏松的加剧。H型高血压可以进一步增加绝经后女性破骨细胞的活性及炎性因子的表达，进而加重骨质疏松症，因此加强对H型高血压患者的血压控制显得尤为重要。

关键词: 高血压, 骨质疏松, 绝经后期, 白介素6, 骨代谢标志物, 炎性因子

CHEN Yuning,WEI Peng,SHI Bimin, et al. Effects of H-type Hypertension on Bone Metabolism Markers and Inflammatory Factors in Postmenopausal Women with Osteoporosis[J]. Chinese General Practice, 2018, 21(32): 3951-3955. DOI: 10.12114/j.issn.1007-9572.2018.32.008.
陈宇宁,魏鹏,施毕旻等. 绝经后女性H型高血压合并骨质疏松症患者骨代谢标志物及炎性因子的变化研究[J]. 中国全科医学, 2018, 21(32): 3951-3955. DOI: 10.12114/j.issn.1007-9572.2018.32.008.

References

［1］FRATONI V，BRANDI M L.Bvitamins，hemocysteine and bone health［J］．Nutrients，2015，7（4）：2176-2192．DOI：10.3390/nu7042176.3954
［2］陈发秀，尹绢，邱元芝.老年骨质疏松和高血压病［J］．中国骨质疏松杂志，2014，20（6）：690-693.3954
CHEN F X，YIN J，QIU Y Z.Osteoporosis and hypertension in the elderly［J］．Chinese Journal of Osteoporosis，2014，20（6）：690-693.3954
［3］张萌萌.中国老年学学会骨质疏松委员会骨代谢生化指标临床应用专家共识［J］．中国骨质疏松杂志，2014，20（11）：1263-1272.3954
ZHANG M M.Expert consensus of clinical application of the bone metabolic and biochemical markers，by Osteoporosis Committee of Chinese Gerontological Society［J］．Chinese Journal of Osteoporosis，2014，20（11）：1263-1272.3954
［4］ERIKSEN C G，OLSEN H，HUSTED L B，et al．The expression of IL-6 by osteoblasts increased in healthy elderly individuals：stimulated proliferation and differentiation are unaffected by age［J］．Calcif Tissue Int，2010，87（5）：414-423．DOI：10.1007/s00223–010-9412-x.3954
［5］中华医学会骨质疏松和骨矿盐疾病分会．原发性骨质疏松症诊疗指南（2011年）［J］．中华骨质疏松和骨矿盐疾病杂志，2011，4（1）：2-17．DOI：10.3639/j.issn.674-25912011.01.002.3954
Chinese Society of Osteoporosis and Bone Mineral Research．Guidelines for the diagnosis and treatment of primary osteoporosis （2011）［J］．Chinese Journal of Osteoporosis and Bone Mineral Research，2011，4（1）：2-17．DOI：10.3639/j.issn.1674-2591 2011.01.002.3954
［6］中国高血压防治指南修订委员会.中国高血压防治指南2010［J］．中华心血管病杂志，2011，39（7）：579-615．DOI：10.3760/cma.j.issn.0253-3758．2011.07.002.3954
Writing Group of 2010 Chinese Guidelines for the Management of Hypertension.2010 Chinese guidelines for the management of hypertension［J］．Chinese Journal of Cardiology，2011，39（7）：579-615．DOI：10.3760/cma.j.issn.0253-3758.2011.07.002.3954
［7］黄媛媛，王覃.骨质疏松症的诊断标准和治疗阈值的相关问题［J］.中国全科医学，2017，20（35）：4347-4353.DOI：10.3969/j.issn.1007-9572.2017.00.134.3954
HUANG Y Y，WANG Q.Related issues in the diagnosis criteria and intervention thresholds of osteoporosis［J］.Chinese General Practice，2017，20（35）：4347-4353.DOI：10.3969/j.issn.1007-9572.2017.00.134.3954
［8］JAMES S J，MIRZA S B，CULLIFORD D J，et al．Baseline bone mineral density and bone turn over in pre-operative hip and knee arthroplasty patients［J］．Bone Joint Res，2014，3（1）：14-19．DOI：10.1302/2046-3758.31.2000218.3954
［9］ARYAEIAN N，SHAHRAM F，DJALALI M.CLA has a useful effect on bone markers in patients with rheumatoid arthritis［J］．Lipids，2016，51（12）：1397-1405．DOI：10.1007/s11745-016-4201-6.3955
［10］YAMAMOTO T，TSUJIMOTO M，HAMAYA E，et al．Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20μg/day administered subcutaneously in Japanese patients with osteoporosis［J］．J Bone Miner Metab，2013，31（2）：199-205．DOI：10.1007/s00774-012-0403-z.3955
［11］YANG S，NGUYEN N D，CENTER J R，et al．Association between hypertension and fragility fracture：a longitudinal study［J］．Osteoporosis Int，2014，25（1）：97-103．DOI：10.1007/s00198-013-2457-8.3955
［12］史大治，王曦云，宋成伟.中老年男性高血压与骨质疏松的关系［J］．中国实用医药，2012，7（18）：55-56．DOI：10.3969/j.issn.1673-7555.2012.18.032.3955
SHI D Z，WANG X Y，SONG C W.The relationship between the hypertetion and osteoporosis in middle aged male［J］．China Practical Medical，2012，7（18）：55-56．DOI：10.3969/j.issn.1673-7555.2012.18.032.3955
［13］ENNEMAN A W，SWART K M，VAN WIJNGAARDEN J P，et al．Effect of vitamin B12 and folic acid supplementation on bone mineral density and quantitative ultrasound parameters in older people with an elevated plasma homocysteine level：B-PROOF，a randomized controlled trial［J］．Calcif Tissue Int，2015，96（5）：401-409．DOI：10.1007/ s00223-015-9968-6.3955
［14］VAN BALLEGOOIJEN A J，KESTENBAUM B，SACHS M C，et al．Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension：MESA （Multi-Ethnic Study of Atherosclerosis）［J］．J Am Coll Cardiol，2014，63（12）：1214-1222．DOI：10.1016/j.jacc.2014.01.012.3955
［15］刘红，廖二元，伍贤平，等．中老年妇女骨转换生化指标和骨密度的变化［J］．中华内分泌代谢杂志，2009，25（2）：164-167．DOI：10.3760/cma.j.issn.1000-6699.2009.02.010.3955
LIU H，LIAO E Y，WU X P，et al．Changes of biochemical markers of bone turnover and bone mineral density in mid- and old-aged women［J］．Chinese Journal of Endocrinology and Metabolism，2009，25（2）：164-167．DOI：10.3760/cma.j.issn.1000-6699.2009.02.010.3955
［16］KOIVULA M K，RISTELI L，RISTELI J.Measurement of aminoterminal propeptide of typeⅠ procollagen （PINP） in serum［J］．Clin Biochem，2012，45（12）：920-927．DOI：10.1016/j.clinbiochem.2012.03.023.3955
［17］陈倩，王会中，高德禄.老年女性骨质疏松症患者骨代谢生化指标的研究［J］．国际检验医学杂志，2011，32（20）：2353-2354．DOI：10.3969/j.issn.1673-4130.2011.20.024.3955
CHEN Q，WANG H Z，GAO D L.The study on bone biochemical markers in old female patients with osteoporosis［J］．International Journal of Laboratory Medicine，2011，32（20）：2353-2354．DOI：10.3969/j.issn.1673-4130.2011.20.024.3955
［18］TATASCIORE A，ZIMARINO M，RENDA G，et al．Awake blood pressure variability，inflammatory markers and target organ damage in newly diagnosed hypertension［J］．Hypertens Res，2008，31（12）：2137-2146．DOI：10.1291/hypres.31.2137.3955

[1]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[2]	XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709.
[3]	CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488.
[4]	BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391.
[5]	ZENG Lingfeng, YANG Weiyi, LIANG Guihong, XIAO Xiao, LUO Minghui, PAN Jianke, HAN Yanhong, HUANG Hetao, ZHAO Jinlong, XU Nanjun, ZHOU Guanghui, ZHANG Xianquan, LIANG Weixiong, OU Aihua, LIU Jun, Bone and Joint Professional Committee of Degeneration and Injury of Guangdong Provincial Association of Chinese Medicine. Expert Questionnaire Survey and Result Analysis of TCM Symptom Assessment in High Risk Population of Osteoporosis in Ling-nan Region [J]. Chinese General Practice, 2023, 26(24): 2986-2991.
[6]	ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049.
[7]	ZUMURETI ·Abudukeyimu, MA Yanlin, ZHU Kairui, LIU Fang, LI Xia. Correlation of Early Growth Response 3 and Interleukin 6 Expression Levels with Coronary Heart Disease [J]. Chinese General Practice, 2023, 26(24): 3016-3021.
[8]	ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777.
[9]	MENG Fan, DONG Minjie, GUO Jin, XU Songtao, YAN Wei, GU Jun, CHEN Yirong, YANG Cheng, WANG Jun, XIA Lifang, CHEN Jun, FU Lingjie. Osteoporosis in Community-dwelling Elderly People: Prevalence and Associated Prevention and Control Strategies in General Practice [J]. Chinese General Practice, 2023, 26(22): 2778-2784.
[10]	XU Haina, AN Miaomiao, ZHU Yan, WU Chunyan, RAN Limei. Associations of Muscle and Adipose Tissue with Bone Mineral Density in Premenopausal and Postmenopausal Women Undergoing Physical Examination [J]. Chinese General Practice, 2023, 26(21): 2626-2631.
[11]	FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580.
[12]	FEI Min, LEI Si, XU Yan, YE Yun, ZHUO Hui, ZHANG Hui, LUO Yingquan. Association of Obstructive Sleep Apnea-hypopnea Syndrome with Blood Pressure Variability and Heart Rate Variability in Patients with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2459-2468.
[13]	YU Tong, YANG Yi, DU Shihong, DING Zihao, HONG Xiuqin. Correlation of Shearing Force and Estradiol with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2469-2475,2495.
[14]	TIAN Meixiang, ZHANG Zhengyi. Standard Management of Hypertension During the Preparation for Pregnancy [J]. Chinese General Practice, 2023, 26(18): 2190-2194.
[15]	LIU Hai, HUANG Guanhua. The Significance of High Normal Blood Pressure for Children and Adolescents [J]. Chinese General Practice, 2023, 26(18): 2183-2189.